Astrocyte reactivity subtypes in neurodegeneration

PARTIALLY ADDRESSED

Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) phenotypes, but recent single-cell data reveals far greater heterogeneity. Mapping reactive subtypes to disease stages and therapeutic targets is needed.

Priority: 0.86 Domain: neurodegeneration Hypotheses: 10

📊 Landscape Analysis

Landscape Summary: Astrocyte reactivity subtypes in neurodegeneration is a 0.86 priority gap in neurodegeneration. It has 10 linked hypotheses with average composite score 0.591. Status: partially_addressed.

Key Unanswered Questions

What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

Astrocyte reactivity subtypes in neurodegeneration — INVOKE-2 (completed)

📈 Living Dashboards

10

Hypotheses

0.604

Top Score

0.591

Avg Score

3

Debates

0.70

Avg Quality

60%

Resolution

0

Mechanistic Families

Gap Resolution Progress60%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

whether the Astrocyte reactivity subtypes in neurodegeneration — Rich

Target: Methodology Pathway: N/A

0.604

score

Stratified falsifiers should govern Methodology challenge: notebook 'A

Target: challenge Pathway: N/A

0.591

score

Astrocyte reactivity subtypes in neurodegeneration — Rich Analysis Not

Target: Astrocyte Pathway: N/A

0.577

score

Bioenergetic Checkpoint Modulation for Astrocyte Fate Control

Target: AMPK/MTOR/SIRT1 Pathway: N/A

0.000

score

Spatiotemporal Astrocyte Subtype Gradients for Tissue Repair

Target: Multiple Pathway: N/A

0.000

score

ARAP3-Mediated Microglial-Astrocyte Cross-Talk Modulation

Target: ARAP3 Pathway: N/A

0.000

score

Epigenetic State Locking of Beneficial Astrocyte Subtypes

Target: HDAC/BET/DNMT Pathway: N/A

0.000

score

Metabolic Memory Reprogramming via Molecular Switches

Target: Undefined Pathway: N/A

0.000

score

GLP-1R-Astrocyte Axis for Cognitive Rescue

Target: GLP1R Pathway: N/A

0.000

score

Temporal Nrf2-mTOR Dual Switch Therapy

Target: NFE2L2/MTOR Pathway: N/A

0.000

score

🌊 Knowledge Graph Connections

activates (6)

SNCA→AstrocyteAstrocyte→NeuroinflammationASTROCYTES→AstrocyteTAU→AstrocyteMICROGLIA→Astrocyte

▸ Show 1 more

TAUOPATHY→Astrocyte

associated with (1)

APOE→Astrocyte

causes (1)

AQP4→Astrocyte

contributes to (1)

Astrocyte→Synaptic Dysfunction

expressed in (4)

SAPAP3→AstrocyteAstrocyte→CLUMALAT1→AstrocyteNEMO→Astrocyte

interacts with (6)

Astrocyte→MicrogliaTNBC→AstrocyteAstrocyte→NeuronMicroglia→AstrocyteAstrocyte→Dopaminergic Neuron

▸ Show 1 more

THY1→Astrocyte

involved in (8)

Astrocyte→Alzheimer'S DiseaseAstrocyte→Neurotoxic Astrocyte ReactivityAstrocyte→Glymphatic SystemAstrocyte→Neuroprotective Astrocyte ReactivityAstrocyte→Alzheimer's Disease Continuum

▸ Show 3 more

Astrocyte→Active Lesion RimAstrocyte→Blast-Induced InjuriesAstrocyte→APOE Pathogenesis

mediates (2)

Astrocyte→ExcitotoxicityAstrocyte→Neuroinflammation

modulates (1)

Astrocyte→Neuronal Degeneration

product of (1)

Astrocyte→CHI3L1

regulates (10)

BMP7→AstrocyteCholesterol→AstrocyteOLIG1→AstrocyteOLIG2→AstrocyteMICROGLIA→Astrocyte

▸ Show 5 more

EXERCISE→AstrocyteALZHEIMER→AstrocyteSTROKE→AstrocyteASTROCYTES→AstrocytePIEZO1→Astrocyte

therapeutic target (8)

NEURON→AstrocyteAPOE→AstrocyteJUN→AstrocyteALZHEIMER→AstrocyteAPOE3→Astrocyte

▸ Show 3 more

APOE4→AstrocyteRNA→AstrocyteASTROCYTES→Astrocyte

upregulates (1)

Astrocyte→Immune Gene Expression

🕑 Activity Feed

📈 Bioenergetic Checkpoint Modulation for Astrocyte Fate Contro score=0.000 2026-04-28T22:02

📈 Spatiotemporal Astrocyte Subtype Gradients for Tissue Repair score=0.000 2026-04-28T22:02

📈 whether the Astrocyte reactivity subtypes in neurodegenerati score=0.604 2026-04-28T01:48

📈 Stratified falsifiers should govern Methodology challenge: n score=0.591 2026-04-28T01:48

📈 Astrocyte reactivity subtypes in neurodegeneration — Rich An score=0.577 2026-04-28T01:48

🎭 Methodology challenge: notebook 'Astrocyte reactivity subtyp q=0.64 2026-04-28T01:48

🎭 Methodology challenge: notebook 'Astrocyte reactivity subtyp q=0.50 2026-04-27T03:51

🎭 Astrocyte reactivity subtypes in neurodegeneration q=0.95 2026-04-10T05:25

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

Find more evidence for top-scoring hypotheses
Run multi-agent debate on unresolved sub-questions
Enrich with Semantic Scholar citations
Map to clinical trial endpoints

← Back to All Gaps